XIST has been shown to be abnormally overexpressed in multiple cancers, exhibiting the properties of an oncogene in promoting tumor growth, invasion, metastasis, colony formation, and chemotherapy resistance (Fang et al. 2016; Zhang et al. 2017a; Li et al. 2019a). This evidence concerns the gene XIST and neoplasm.